+3S specializes in the research, development, production and operation of antitoxin and antiserum biological products.
Serum Biotech is a high-tech enterprise specialized in research, development, production, and sales of antitoxin and antiserum products in China.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 27, 2016 | Post-IPO Equity | ¥50M | 3 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Tibet Jiuzheng Capital Investment | — | Post-IPO Equity |
Optical Valley Venture Capital | — | Post-IPO Equity |
Ch-gemstone capital | — | Post-IPO Equity |